Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-08 · accession 0001209191-21-060264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-12 | 2021-10-08 | QNCX | McLoughlin Margaret | Dir | S - Sale+OE | $88.93 | -1,000 | 0 | -100% | -$88.9K |
| D | 2021-10-12 | 2021-10-08 | QNCX | McLoughlin Margaret | Dir | M - OptEx | $17.00 | +1,000 | 1,000 | New | +$17.0K |
| D | 2021-10-12 | 2021-10-08 | QNCX | McLoughlin Margaret | Dir | M - OptEx | $0.00 | -1,000 | 84.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-08 | S | D | 1,000 | $88.93 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-08 | M | A | 1,000 | $17.00 | 1,000 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-10-08 | M | D | 1,000 | $0.00 | 84,911 | D | $17.00 · — to 2029-05-07 | 1,000 Common Stock | (F2) The option vested as to 1/3rd of the shares on May 8, 2020, with the remaining 2/3rd of shares vesting in equal monthly installments beginning on June 8, 2020 and ending on May 8, 2022. |